4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-25-000014
PRESIDENT AND CFO sold 8,000 shares at an average $83.85 ($670,823)
- PRESIDENT AND CFO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
GUGGENHIME ANDREW · PRESIDENT AND CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,000 | $5.35 | $42,800 | 117,491 | D |
| 2025-02-18 | Sale : show line 2 in the form 10b5-1 | −6,182 | $83.64 | $517,056 | 111,309 | D |
| 2025-02-18 | Sale : show line 3 in the form 10b5-1 | −1,818 | $84.58 | $153,766 | 109,491 | D |
| Open-market sales · 8,000 sh · avg $83.85 · $670,823 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-18 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) | −8,000 | 246,827 | D |
Loading xslF345X05/wk-form4_1740006233.xml…